CLINICAL_TRIALS
trial_result
· 2018-08-28
Clinical Trial Update: An Open-label Phase II Study of Lorvotuzumab Mertansine [Phase 2]
Summary
Open-label Phase II trial of Lorvotuzumab Mertansine (IMG_???), completed with results posted in 2018 for leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-08-28